Amrn stock price at $1

At $1.13, AMRN stock price reflects cautious optimism as bullish traders point to RSI nearing oversold territory, possibly triggering rebound opportunities. However, net product revenues from Vazkepa sales are likely to have increased substantially in the European markets during the second quarter. Vazkepa sales have been gaining momentum in the EU, primarily driven by revenue growth in the United Kingdom and Spain. Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators. This uptick aligns with rumors of potential European market growth for Vascepa.